Xu, C.; Soragni, E.; Jacques, V.; Rusche, J.R.; Gottesfeld, J.M.
Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route. Pharmaceuticals 2011, 4, 1578-1590.
https://doi.org/10.3390/ph4121578
AMA Style
Xu C, Soragni E, Jacques V, Rusche JR, Gottesfeld JM.
Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route. Pharmaceuticals. 2011; 4(12):1578-1590.
https://doi.org/10.3390/ph4121578
Chicago/Turabian Style
Xu, Chunping, Elisabetta Soragni, Vincent Jacques, James R. Rusche, and Joel M. Gottesfeld.
2011. "Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route" Pharmaceuticals 4, no. 12: 1578-1590.
https://doi.org/10.3390/ph4121578
APA Style
Xu, C., Soragni, E., Jacques, V., Rusche, J. R., & Gottesfeld, J. M.
(2011). Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route. Pharmaceuticals, 4(12), 1578-1590.
https://doi.org/10.3390/ph4121578